Invest with Eyecarrot

Why Invest

Eyecarrot is a technology company transforming vision performance for the 1 in 4 people worldwide that suffer from vision-related issues beyond visual acuity.

  • 1
    Discover a high-growth technology company that’s poised to transform how the world thinks about vision performance
  • 2
    Discover a young company, publicly traded with a proven management team
  • 3
    Discover a highly-scalable, recurring-revenue business model that fully integrates software, hardware and expert insights

Fact Sheet

Eyecarrot Innovations Corp
tsx.v
eyc
otcqb
eyccf
fra 2ey
Market Capitalization $12MM cad
Capital Structure
(March 31 2017)
Shares Issued & Outstanding
62,311,632
Warrants
9,445,332
Options 7,060,000
Total Shares (Fully Diluted) 78,816,964

The Eyecarrot Solution

Address core problems and expand the reach of vision therapy to transform human vision performance globally

Deliver an Exceptional Patient Experience

Leverage modern technology to replace the status quo, simplify the process and making vision therapy a more familiar, patient-friendly experience.

  • Customized plans with expert video instruction
  • Full set of reporting tools and alerts to track and monitor compliance.
  • Automated data capture and built-in secure messaging
  • Help professionals save time and work with more patients tailored to their coverage, affordability or access
  • Simple powerful lead generation and referral engine

Make the Tools Low-Cost & Accessible to All

Improve the established industry tools, lowering the cost of entry.

  • Next-generation, full-sensory, testing and training device
  • Eye Movement, Eye-hand Coordination, Reaction Time, Visual Memory, Accommodation, Vergence, Visual / Tactile / Auditory training (multi-sensory)
  • Industry standard for concussion patients and sports vision training
  • Huge potential in Education (ADHD and learning disabilities) and Healthy Aging applications (e.g., seniors driving licenses)

Integrate, Track, and Measure the Data

Using hardware and software to collect and organize patient-related data to track progress, results, and outcomes.

  • Use data and machine learning to optimize treatment protocols, help accelerate recovery, and improve patient outcomes
  • Leverage data network effect – value of incremental data is compounded with time

Concussion Case Study

Trauma

Data Collected

Diagnosis & Prescription

Patient Profile
Type of Trauma
Effective Activities

Testing & Rehabilitation

Visual, Auditory, Tactile
Performance Data
Population Norms

Home Therapy

Compliance
Symptoms
Recovery Roadmap

Recovery

Outcome
Timeframe

International Partner Network

We are proud to serve more than 1,500 vision therapy and vision training clinics in over 20 countries and we want to double that by the end of 2018. Come join us and make a difference.

Vision Therapy Clinics Using Eyecarrot
  • OEP

    Worldwide

  • COVT&R + COVD Canada

    Canada

  • COVD + NORA

    United States

  • BABO

    United Kingdom

  • SIODEC

    Spain

  • BOAF

    Germany

  • ACBO

    Australasia

  • COMOF

    Mexico

The Eyecarrot Team

Management Team

Headshot - Adam Cegielski - 04

Adam Cegielski

Founder & CEO

Dr. Sam Mithani

Dr. Sam Mithani

PhD

Chief Technology Officer

Headshot - Selwyn Super - 01

Dr. Selwyn Super

FAAO, B.Ed., M.Ed., PhD

Chief Scientific Officer

Board of Directors

Headshot - John Flanagan - 01

Dr. John G Flanagan

OD, PhD, faao

Board of Directors

Headshot - David Schmidt - 01

David Schmidt

Board of Directors

sean-c

Sean Charland

Board of Directors

Special Advisors

dr-robert-sanet

Dr. Robert Sanet

od, F.covd

Special Advisor – Behavioural Optometry & Vision Training

drleonardpress

Dr. Leonard Press

od, F.covd, faao

Director of Global Education

patrick-q

Dr. Patrick Quaid

MCOptom, F.covd, PhD

Chief Scientific Advisor

Bryce Salvador

Bryce Salvador

Sports Performance and Athletics

Headshot - Joe Lia - 07

Joe Lia

Director of Video Production

Headshot - Todd Finch - 02

Todd Finch

Technology & Business Development